Edgestream Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
6,848
-101,966
-94% -$5.24M 0.01% 854
2026
Q1
$6.45M Sell
108,814
-59,627
-35% -$3.87M 0.21% 154
2025
Q4
$10.4M Buy
168,441
+59,417
+54% +$3.64M 0.29% 56
2025
Q3
$6.8M Sell
109,024
-26,487
-20% -$1.84M 0.2% 162
2025
Q2
$10.8M Buy
+135,511
New +$11.3M 0.3% 55
2024
Q4
Sell
-54,747
Closed -$3.95M 1030
2024
Q3
$3.95M Buy
+54,747
New +$3.88M 0.17% 191
2023
Q4
Sell
-8,839
Closed -$506K 1004
2023
Q3
$506K Buy
+8,839
New +$534K 0.04% 591

Other funds holding PBH

Edgestream Partners's PBH Position: Q2 2026 in Review

Edgestream Partners reduced its Prestige Consumer Healthcare (PBH) stake by 94% in Q2 2026, selling an estimated $5.24M and leaving 6,848 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #854.

Edgestream Partners first reported a position in PBH in Q3 2023 and has held it in 7 quarters since. The position peaked at $10.8M in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Edgestream Partners held 6,848 shares of Prestige Consumer Healthcare worth $324K as of Q2 2026.
  • Edgestream Partners sold 101,966 Prestige Consumer Healthcare shares in Q2 2026, an estimated $5.24M.
  • Prestige Consumer Healthcare made up 0.01% of Edgestream Partners's portfolio in Q2 2026, its #854 holding.
  • Edgestream Partners first reported a position in Prestige Consumer Healthcare in Q3 2023 and has held it in 7 quarters since.
  • Edgestream Partners's Prestige Consumer Healthcare position peaked at $10.8M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.